
|Articles|March 3, 2017
Pharmacy Week in Review: March 3, 2017
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Advertisement
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Metformin Cuts Long COVID Risk by 50%, New Trial Confirms
2
FDA Approves Capvaxive Expanded Indication to Include Children, Adolescents at Increased Risk for Pneumococcal Disease
3
Phase 3 MonumenTAL-3 Trial Demonstrates Significant Survival Benefit With Talquetamab-Based Regimens in Relapsed/Refractory Multiple Myeloma
4
FDA Clears First Single-Inhaler Triple Therapy for Asthma
5
















































































































